Roles of cytochrome P450 2A6 in the oxidation of flavone, 4′-hydroxyflavone, and 4′-, 3′-, and 2′-methoxyflavones by human liver microsomes

References

• Akashi T, Aoki T, Ayabe S. 1998. Identification of a cytochrome P450 cDNA encoding (2S)-flavanone 2-hydroxylase of licorice (Glycyrrhiza echinata L.; Fabaceae) which represents licodione synthase and flavone synthase II. FEBS Lett. 431(2):287–290.
   PubMed Web of Science ®Google Scholar
• Akashi T, Fukuchi-Mizutani M, Aoki T, Ueyama Y, Yonekura-Sakakibara K, Tanaka Y, Kusumi T, Ayabe S. 1999. Molecular cloning and biochemical characterization of a novel cytochrome P450, flavone synthase II, that catalyzes direct conversion of flavanones to flavones. Plant Cell Physiol. 40(11):1182–1186.
   PubMed Web of Science ®Google Scholar
• Arct J, Pytkowska K. 2008. Flavonoids as components of biologically active cosmeceuticals. Clin Dermatol. 26(4):347–357.
   PubMed Web of Science ®Google Scholar
• Breinholt VM, Offord EA, Brouwer C, Nielsen SE, Brøsen K, Friedberg T. 2002. In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol. 40(5):609–616.
   PubMed Web of Science ®Google Scholar
• Brown RE, Jarvis KL, Hyland KJ. 1989. Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem. 180(1):136–139.
   PubMed Web of Science ®Google Scholar
• Das NP, Griffiths LA. 1966. Studies on flavonoid metabolism. Metabolism of flavone in the guinea pig. Biochem J. 98(2):488–492.
   PubMed Web of Science ®Google Scholar
• DeVore NM, Scott EE. 2012. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes. J Biol Chem. 287(32):26576–26585.
   PubMed Web of Science ®Google Scholar
• Du Y, Chu H, Chu IK, Lo C. 2010. CYP93G2 is a flavanone 2-hydroxylase required for C-glycosylflavone biosynthesis in rice. Plant Physiol. 154(1):324–333.
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Abedi F, Samarghandian S. 2019. Chrysin attenuates inflammatory and metabolic disorder indices in aged male rat. Biomed Pharmacother. 109:1120–1125.
   PubMed Web of Science ®Google Scholar
• Fliegmann J, Furtwängler K, Malterer G, Cantarello C, Schüler G, Ebel J, Mithöfer A. 2010. Flavone synthase II (CYP93B16) from soybean (Glycine max L.). Phytochemistry. 71(5–6):508–514.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 2014. Analysis and characterization of enzymes and nucleic acids relevant to toxicology. In: Hayes AW, Kruger CL, editors. Principles and methods of toxicology. 6th ed. Boca Raton, FL: Taylor and Francis; p. 1905–1964.
   Google Scholar
• Guengerich FP. 2015. Human cytochrome P450 enzymes. In: Ortiz de MPR, editor. Cytochrome P450: structure, mechanism, and biochemistry. 4th ed. New York: Springer; p. 563–785.
   Google Scholar
• Han S, Choi S, Chun Y-J, Yun C-H, Lee CH, Shin HJ, Na HS, Chung MW, Kim D. 2012. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol Pharm Bull. 35(3):394–399.
   PubMed Web of Science ®Google Scholar
• Hedin PA, Phillips VA. 1992. Electron impact mass spectral analysis of flavonoids. J Agric Food Chem. 40(4):607–611.
   Web of Science ®Google Scholar
• Hodek P, Trefil P, Stiborová M. 2002. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact. 139(1):1–21.
   PubMed Web of Science ®Google Scholar
• Kagawa H, Takahashi T, Ohta S, Harigaya Y. 2004. Oxidation and rearrangements of flavanones by mammalian cytochrome P450. Xenobiotica. 34(9):797–810.
   PubMed Web of Science ®Google Scholar
• Kakimoto K, Murayama N, Takenaka S, Nagayoshi H, Lim Y-R, Kim V, Kim D, Yamazaki H, Komori M, Guengerich FP, et al. 2019. Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone. Xenobiotica. 49(2):131–142.
   PubMed Web of Science ®Google Scholar
• Kale A, Gawande S, Kotwal S. 2008. Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother Res. 22(5):567–577.
   PubMed Web of Science ®Google Scholar
• Kim V, Yeom S, Lee Y, Park H-G, Cho M-A, Kim H, Kim D. 2018. In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10. J Toxicol Environ Health A. 81(12):493–501.
   PubMed Web of Science ®Google Scholar
• Kim N, Yoo HS, Ju YJ, Oh MS, Lee KT, Inn KS, Kim NJ, Lee JK. 2018. synthetic 3′,4′-dihydroxyflavone exerts anti-neuroinflammatory effects in BV2 microglia and a mouse model. Biomol Ther. 26(2):210–217.
   PubMed Web of Science ®Google Scholar
• Li Q-S, Li C-Y, Li Z-L, Zhu H-L. 2012. Genistein and its synthetic analogs as anticancer agents. Anticancer Agents Med Chem. 12(3):271–281.
   PubMed Web of Science ®Google Scholar
• Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng P, Chen A, Huang H. 2016. The Fascinating Effects of Baicalein on Cancer: A Review. IJMS. 17(10):1681.
   Web of Science ®Google Scholar
• Madunić J, Madunić IV, Gajski G, Popić J, Garaj-Vrhovac V. 2018. Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Lett. 413:11–22.
   PubMed Web of Science ®Google Scholar
• Martens S, Mithöfer A. 2005. Flavones and flavone synthases. Phytochemistry. 66(20):2399–2407.
   PubMed Web of Science ®Google Scholar
• Nabavi SM, Habtemariam S, Daglia M, Nabavi SF. 2015. Apigenin and Breast Cancers: From Chemistry to Medicine. Anticancer Agents Med Chem. 15(6):728–735.
   PubMed Web of Science ®Google Scholar
• Nagayoshi H, Murayama N, Kakimoto K, Takenaka S, Katahira J, Lim YR, Kim V, Kim D, Yamazaki H, Komori M, et al. 2019a. Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes. Xenobiotica. 49(7):791–802.
   PubMed Web of Science ®Google Scholar
• Nagayoshi H, Murayama N, Kakimoto K, Tsujino M, Takenaka S, Katahira J, Lim Y-R, Kim D, Yamazaki H, Komori M, et al. 2019b. Oxidation of flavone, 5-hydroxyflavone, and 5,7-dihydroxyflavone to mono-, di-, and tri-hydroxyflavones by human cytochrome P450 enzymes. Chem Res Toxicol. 32(6):1268–1280.
   PubMed Web of Science ®Google Scholar
• Nagayoshi H, Murayama N, Tsujino M, Takenaka S, Katahira J, Kim V, Kim D, Komori M, Yamazaki H, Guengerich FP, et al. 2020. Preference for O-demethylation reactions in the oxidation of 2′-, 3′-, and 4′-methoxyflavones by human cytochrome P450 enzymes. Xenobiotica. 50(10):1158–1169.
   PubMed Web of Science ®Google Scholar
• Nelson D, Werck-Reichhart D. 2011. A P450-centric view of plant evolution. Plant J. 66(1):194–211.
   PubMed Web of Science ®Google Scholar
• Nikolic D, van Breemen RB. 2004. New metabolic pathways for flavanones catalyzed by rat liver microsomes. Drug Metab Dispos. 32(4):387–397.
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem. 239:2370–2378.
   PubMed Web of Science ®Google Scholar
• Parikh A, Gillam EMJ, Guengerich FP. 1997. Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol. 15(8):784–788.
   PubMed Web of Science ®Google Scholar
• Patel D, Shukla S, Gupta S. 2007. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol. 30(1):233–245.
   PubMed Web of Science ®Google Scholar
• Samarghandian S, Afshari JT, Davoodi S. 2011. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics (Sao Paulo). 66(6):1073–1079.
   PubMed Web of Science ®Google Scholar
• Sandhu P, Baba T, Guengerich FP. 1993. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys. 306(2):443–450.
   PubMed Web of Science ®Google Scholar
• Sandhu P, Guo Z, Baba T, Martin MV, Tukey RH, Guengerich FP. 1994. Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch Biochem Biophys. 309(1):168–177.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Itagaki Y, Kurokawa T, Watanabe E, Aoyama T. 1966. The mass spectra of flavonoids. Mass Spectroscopy. 14(2):82–92.
   Google Scholar
• Schlupper D, Giesa S, Gebhardt R. 2006. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3′,4′-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity. Planta Med. 72(7):596–603.
   PubMed Web of Science ®Google Scholar
• Shen AL, Porter TD, Wilson TE, Kasper CB. 1989. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem. 264(13):7584–7589.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Chen Y, Wang L, Liu G, Li W, Tang Y. 2014. Effects of protein flexibility on the site of metabolism prediction for CYP2A6 substrates. J Mol Graph Model. 54:90–99.
   PubMed Web of Science ®Google Scholar
• Shimada T. 2017. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicol Res. 33(2):79–96.
   PubMed Web of Science ®Google Scholar
• Shimada T. 2006. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 21(4):257–276.
   PubMed Web of Science ®Google Scholar
• Shimada T, Murayama N, Kakimoto K, Takenaka S, Lim YR, Yeom S, Kim D, Yamazaki H, Guengerich FP, Komori M. 2018. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants. Xenobiotica. 48(6):565–575.
   PubMed Web of Science ®Google Scholar
• Shimada T, Watanabe J, Inoue K, Guengerich FP, Gillam EMJ. 2001. Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica. 31(3):163–176.
   PubMed Web of Science ®Google Scholar
• Shimada T, Nagayoshi H, Murayama N, Takenaka S, Katahira J, Kim V, Kim D, Komori M, Yamazaki H, Guengerich FP. 2021. Liquid chromatography-tandem mass spectrometry analysis of oxidation of 2′-, 3′-, 4′- and 6-hydroxyflavanones by human cytochrome P450 enzymes . Xenobiotica. 51(2):139–154.
   PubMed Web of Science ®Google Scholar
• Su T, Bao ZP, Zhang QY, Smith TJ, Hong JY, Ding X. 2000. Human cytochrome P450 CYP2A13. Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 60(18):5074–5079.
   PubMed Web of Science ®Google Scholar
• Surichan S, Arroo RR, Ruparelia K, Tsatsakis AM, Androutsopoulos VP. 2018. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food Chem Toxicol. 113:228–235.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Brugliera F. 2013. Flower colour and cytochromes P450. Philos Trans R Soc Lond B Biol Sci. 368:1–14.
   Web of Science ®Google Scholar
• Tanaka Y, Brugliera F, Kalc G, Senior M, Dyson B, Nakamura N, Katsumoto Y, Chandler S. 2010. Flower color modification by engineering of the flavonoid biosynthetic pathway: practical perspectives. Biosci Biotechnol Biochem. 74(9):1760–1769.
   PubMed Web of Science ®Google Scholar
• Tsimogiannis D, Samiotaki M, Panayotou G, Oreopoulou V. 2007. Characterization of flavonoid subgroups and hydroxy substitution by HPLC-MS/MS. Molecules. 12(3):593–606.
   PubMed Web of Science ®Google Scholar
• Uno T, Obe Y, Ogura C, Goto T, Yamamoto K, Nakamura M, Kanamaru K, Yamagata H, Imaishi H. 2013. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. Biopharm Drug Dispos. 34(2):87–97.
   PubMed Web of Science ®Google Scholar
• Uno T, Ogura C, Izumi C, Nakamura M, Yanase T, Yamazaki H, Ashida H, Kanamaru K, Yamagata H, Imaishi H. 2015. Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids. Biopharm Drug Dispos. 36(8):552–563.
   PubMed Web of Science ®Google Scholar
• Walle UK, Walle T. 2007. Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. Drug Metab Dispos. 35(11):1985–1989.
   PubMed Web of Science ®Google Scholar
• Wei K, Chen H. 2018. Global identification, structural analysis and expression characterization of cytochrome P450 monooxygenase superfamily in rice. BMC Genomics. 19(1):35–18.
   PubMed Web of Science ®Google Scholar
• Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, Cashman JR. 2006. Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 49(24):6987–7001.
   PubMed Web of Science ®Google Scholar
• Yun C-H, Shimada T, Guengerich FP. 1991. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 40(5):679–685.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang X, Coburn RA, Morris ME. 2005. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol. 70(4):627–639.
   PubMed Web of Science ®Google Scholar